Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
115 participants
OBSERVATIONAL
2004-01-01
2017-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?
NCT06777017
The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC
NCT04800497
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis
NCT03083002
Evaluation of Risk of hEpatocellular Carcinoma
NCT06523179
The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study
NCT01831037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Similarly, patients operated for recurrent HCC or with non-radical surgery or with missing data were excluded.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Guido Torzilli
Professor of Surgery, Director Department of Hepatobiliary and General Surgery
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FLNA in HCC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.